Alta Wealth Advisors LLC Has $1.40 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Alta Wealth Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,771 shares of the healthcare conglomerate's stock after selling 560 shares during the period. Alta Wealth Advisors LLC's holdings in UnitedHealth Group were worth $1,402,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the third quarter worth approximately $27,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $30,000. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after purchasing an additional 32 shares in the last quarter. West Financial Advisors LLC bought a new stake in UnitedHealth Group during the third quarter worth approximately $32,000. Finally, Quarry LP raised its holdings in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock worth $33,000 after purchasing an additional 37 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on UNH shares. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a report on Wednesday, October 16th. KeyCorp reiterated an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Stock Down 0.6 %

NYSE:UNH traded down $3.27 during trading hours on Friday, reaching $542.30. The company's stock had a trading volume of 4,120,450 shares, compared to its average volume of 4,544,639. The company has a market cap of $499.07 billion, a price-to-earnings ratio of 34.99, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business's 50-day moving average is $537.14 and its 200-day moving average is $564.96. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group's dividend payout ratio is 54.19%.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.